HTG Molecular Diagnostics Inc - SIC # 3826 - LABORATORY ANALYTICAL INSTRUMENTS

Ticker Exchange SIC # Website Latest Ticker
HTGM Nasdaq 3826 https://www.htgmolecular.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for HTG Molecular Diagnostics Inc

HTG Provides a Year-End Update on its Drug Discovery Business and Attends LifeSci Partners 2023 Corporate Access Event - Jan 9th, 2023 1:33 pm
HTG Announces Certain Preliminary 2022 Unaudited Financial Results - Jan 6th, 2023 1:00 pm
HTG Molecular Diagnostics Provides Highlights of its Second Event in Drug Discovery KOL Webcast Series - Dec 28th, 2022 1:00 pm
HTG Molecular Diagnostics Announces Closing of a $10 Million Public Offering - Dec 23rd, 2022 9:05 pm
HTG Molecular Diagnostics Announces Pricing of a $10 Million Public Offering - Dec 21st, 2022 6:15 pm
HTG Announces One-for-Twelve Reverse Stock Split - Dec 20th, 2022 9:30 pm
12 Low Float Stocks With High Volume - Dec 13th, 2022 2:11 pm
HTG Molecular Diagnostics Announces the Next Event in its RNA Profiling in Drug Discovery KOL Webcast Series - Dec 9th, 2022 1:01 pm
HTG Technology Featured Across Numerous Abstracts at Upcoming Scientific Conferences - Dec 6th, 2022 1:00 pm
HTG Molecular Diagnostics, Inc. (HTGM) Reports Q3 Loss, Misses Revenue Estimates - Nov 10th, 2022 11:35 pm
HTG Molecular Diagnostics Reports Third Quarter 2022 Results - Nov 10th, 2022 9:05 pm
ReWalk Robotics (RWLK) Reports Q3 Loss, Lags Revenue Estimates - Nov 7th, 2022 2:15 pm
HTG to Collaborate With OmiCure, Providing Transcriptomic Data Across Several Cancer Indications - Oct 26th, 2022 12:00 pm
HTG Provides Update on Third Quarter Progress Toward Its Transcriptome-Informed Approach to Drug Discovery - Oct 12th, 2022 8:05 pm
HTG Molecular Diagnostics to Participate in the Cantor Fitzgerald Oncology, Hematology & HemeOnc Conference - Sep 26th, 2022 12:00 pm
HTG Molecular Diagnostics, Inc. (HTGM) Moves to Buy: Rationale Behind the Upgrade - Sep 21st, 2022 4:00 pm
The Fundación Instituto Valenciano de Oncología Leverages HTG Technology for Breast Cancer Laboratory-Developed Test - Sep 20th, 2022 8:05 pm
Edited Transcript of HTGM.OQ earnings conference call or presentation 11-Aug-22 8:30pm GMT - Aug 11th, 2022 8:30 pm
HTG Molecular Diagnostics Reports Second Quarter 2022 Results - Aug 11th, 2022 8:05 pm
Inogen (INGN) Reports Q2 Loss, Tops Revenue Estimates - Aug 4th, 2022 11:15 pm